We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
1 hedge funds and large institutions have $25 invested in CASI Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
10.18% less ownership
Funds ownership: 10.18% → 0% (-10%)
94% less funds holding
Funds holding: 16 → 1 (-15)
100% less capital invested
Capital invested by funds: $1.06M → $25 (-$1.06M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
Holders
1
Holders Change
-15
Holders Change %
-93.75%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$86 |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$839K |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$113K |
| 3 |
Renaissance Technologies
New York
|
-$36.6K |
| 4 |
Two Sigma Investments
New York
|
-$20.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$16.9K |
